Relay Therapeutics, Inc. (RLAY) has been beaten down lately with too much selling pressure. While the stock has lost 27.9% over the past four weeks, there is light at the end of the tunnel as it ...

This study aims to investigate the effect of reducing the duration of cardiopulmonary bypass by utilizing the off-pump coronary artery bypass grafting (OPCABG) technique on the short-term prognosis of ...